Combination Therapy for lung cancer treatment is one of the latest, most exciting advances in lung cancer research.
Studies of patients being treated with combination therapy show increase in the overall survival rate for lung cancer patients.
In the 1970s, researchers discovered that using a combination of drugs to treat a cancer patient increases the chance that all of the cancer cells will be eliminated. Preliminarily, clinical trials have shown that the combination of immunotherapy with other therapy, such as chemotherapy, radiotherapy, and targeted therapy, achieve greater therapeutic effects for treating small cell lung cancer (SCLC).
Some of the positive reasons doctors may choose to recommend combination therapy for certain lung cancer patients are:
- A single treatment might not be sufficient to make the tumor shrink.
- Sometimes adding an additional treatment may make the original treatment work better.
- Certain treatments might be more effective at different stages of your treatment journey.
Types of Treatment